Rob Hamilton Email & Phone Number

Toronto, On, Ca

Burlington Ontario Canada

I am very pleased to announce the launch of my new hearing clinic, Hearing Well Matters!, in Burlington Ontario (www.hearingwellmatters.ca,), effective January 2020. After spending the last 20 years leading the build-out (UCB Canada, InterMune) and recovery (Biogen Idec, Starkey Hearing Technologies) of four Canadian affiliates of multinational health companies, I am excited to launch my own clinic to help patients living with hearing loss. Hearing loss is the third most common chronic health condition (> 8 million Canadians), and untreated hearing loss is the leading modifiable risk factor for early cognitive decline and dementia. On a personal note, I found myself having communication challenges discriminating speech in background noise and asking others to repeat themselves. I was diagnosed with high frequency hearing loss and fit with digital hearing instruments in 2018. I look forward to hearing from old friends and colleagues as I start this exciting new venture! info@hearingwellmatters.ca 905-681-HEAR (4327) 905-220-6010 (cell)

Toronto, Ontario

A strategic management consulting firm focused on multinational affiliate start-up and successful commercialization of pharmaceutical, biotech and orphan disease products in Canada.Works with senior commercial management in U.S. and European companies to help assess Canadian biopharma market potential for their products, and plan optimal Canadian market entry strategies.

Mississauga, Ontario

• Leading commercial and administrative operations of Starkey Hearing in Canada .• Maximization of sales revenue and income for marketed Starkey audiology products • Aligning Canadian business operations and strategies with Starkey's worldwide strategies; development of local strategic plans and implementation of operational tactical plans to achieve agreed-upon commercial goals • Representation of Starkey to external stakeholders in Canada (e.g., audiologists, physicians, payers, regulators, etc.)• Coordinating and managing Marketing & Sales, Customer Service, Education & Training, Production, Quality, Logistics, Finance and HR staff • Attraction and retention of talented employees• Led significant turn-around in market share (+1.5%), unit volume (+15%) and $ revenue (+5%) while consolidating Canadian organization from 100 to 80 employees

Toronto, Ontario

• Established, set-up and launched InterMune commercial affiliate operation in Canada• Developed and executed commercial plans with full P&L responsibility for Esbriet®, a first-in-class therapeutic for the treatment of Idiopathic Pulmonary Fibrosis• Aligned Canadian business operations and strategies with global strategies; developed national strategic and operational plans; • Interfaced with Canadian stakeholders (physicians, health professionals, payers, regulators, etc.)• Hired and oversaw commercial business unit personnel, medical affairs, finance, human resources, IT, and regulatory • Developed an appropriate positive corporate image for company in Canada with medical stakeholders, patient advocacy groups, industry associations and government decision-makers* First year sales at $6.9M and 295 reimbursed patients surpassed all other InterMune affiiates per capita

Burlington, Ontario

Responsibilities:• Starting up, launching and building out the UCB Canadian affiliate operation• Leading all commercial and administrative activities of UCB Pharma Canada Inc. • Maximization of sales revenue and income for marketed UCB products (i.e., DIPENTUM®, KEPPRA®) in Canada; preparation of Canadian market for future UCB products (e.g., CIMZIATM, NEUPROTM, VIMPATTM)• Aligning Canadian business operations and strategies with UCB’s worldwide strategies; development of local strategic plans and implementation of operational tactical plans to achieve agreed-upon commercial goals • Representation of UCB to external stakeholders in Canada (e.g., physicians, payers, regulators, etc.)• Coordinating and managing regulatory and medical research personnel from UCB operations with respect to clinical investigations and registrations in Canada• Human resource development of Canadian employees into a self-reliant organization; attraction and retention of talented employees• Development of an appropriate corporate image for UCB in CanadaAchievements• Developed and executed commercial plan to launch Canadian affiliate• Led legal incorporation of company and successfully kicked off business in Canada via Belgian Royal Trade Mission to Canada• Built out Canadian affiliate into fully functionalized organization, using a combination of full-time and contract staff• Led implementation of local financial, human resource, logistic and compliance control systems • Repatriated products from Lundbeck Canada via New Business Development to optimize local P&L• Led successful pre-market development of Rheumatology, Gastroenterology and Neurology segments to prepare for product introductions

Mississauga, Ontario

Responsibilities:• Leading all commercial and administrative activities of company in Canada • Maximization of sales revenue and income for marketed products (i.e., AVONEX®, AMEVIVE®) in Canada; preparation of Canadian market for future products (e.g., TYSABRI)• Aligning Canadian business operations and strategies with worldwide strategies; development of local strategic plans and implementation of operational tactical plans to achieve agreed-upon commercial goals • Representation to external stakeholders in Canada (e.g., physicians, payers, regulators)• Coordinating and managing regulatory and medical research personnel from Biogen Idec’s U.S. operations with respect to clinical investigations and registrations in Canada• Human resource development of Canadian employees into a self-reliant organization; attraction and retention of employees• Development of an appropriate corporate image for Biogen Idec CanadaAccomplishments:• Total sales turnover increased from $ 24 M to $58 M CAD, overall contribution margin increased from 29% to 48% and full-time headcount grew from 21 to 45 over 2003-2005 period• Successfully repositioned and resuscitated the growth of Avonex®, making it the fastest-growing MS product • Successfully launched Amevive®, the first biological approved in Canada for the treatment of moderate to severe psoriasis; first year sales = $ 19.0 M CAD• Led pre-launch planning effort and execution of market development of Tysabri for the treatment of MS• Developed several employees for promotions and global assignments• Significantly increased corporate image in Canada

Misssissauga, Ontario

Oversaw re-launch of Avonex in Multiple Sclerosis and launch of Amevive in Plaque Psoriasis

Master Of Business Administration (M.B.A.), Marketing

Life Sciences, Pharmacology